Medication nonadherence in Parkinson's disease.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

16 citing papers in PubMed.

1. Characteristics and Hospitalization Details of Patients with Advanced Parkinson's Disease Receiving Continuous Subcutaneous Infusion of Foslevodopa/Foscarbidopa: Real-World First-Year Descriptive Study from Japan.Neurology and therapy · 2026
   Article
2. Motor and non-motor fluctuations in Parkinson's disease: the knowns and unknowns of current therapeutic approaches.Journal of neural transmission (Vienna, Austria : 1996) · 2026
   Review
3. Assessing the impact of automated devices for enhancing health and reducing medication errors in older adults with long-term health conditions (ADHERE): a study protocol for a randomised controlled trial in Bedfordshire, Luton and Milton Keynes, UK.BMJ open · 2026
   Article
4. Versatility of Transcranial Magnetic Stimulation: A Review of Diagnostic and Therapeutic Applications.Brain sciences · 2026
   Review
5. Adherence to Parkinson's disease medication: A case study to illustrate reasons for non-adherence, implications for practice and engaging under-represented participants in research.Exploratory research in clinical and social pharmacy · 2024
   Article
6. Comparative Effectiveness of Carbidopa-Levodopa Enteral Suspension and Deep Brain Stimulation on Parkinson's Disease-Related Pill Burden Reduction in Advanced Parkinson's Disease: A Retrospective Real-World Cohort Study.Neurology and therapy · 2022
   Article
7. Should "on-demand" treatments for Parkinson's disease OFF episodes be used earlier?Clinical parkinsonism & related disorders · 2022
   Review
8. Advanced Parkinson's Disease Treatment Simplification and Long-Term Outcomes with Levodopa Carbidopa Intestinal Gel: COSMOS Romanian Subanalysis.Brain sciences · 2021
   Article
9. An Innovative Personalised Management Program for Older Adults with Parkinson's Disease: New Concepts and Future Directions.Journal of personalized medicine · 2021
   Review
10. A post hoc comparison of levodopa-carbidopa intestinal gel daytime monotherapy vs polytherapy safety and efficacy in patients with advanced Parkinson's disease: Results from 6 phase 3/3b open-label studies.Clinical parkinsonism & related disorders · 2020
    Article
11. Association Between Nonmotor Symptoms and Nonadherence to Medication in Parkinson's Disease.Frontiers in neurology · 2020
    Article
12. What Predicts Different Kinds of Nonadherent Behavior in Elderly People With Parkinson's Disease?Frontiers in medicine · 2020
    Article
13. Patient and physician perceptions of disease management in Parkinson's disease: results from a US-based multicenter survey.Neuropsychiatric disease and treatment · 2019
    Article
14. Levodopa-Carbidopa Intestinal Gel Monotherapy: GLORIA Registry Demographics, Efficacy, and Safety.Journal of Parkinson's disease · 2019
    Observational
15. Using a smartphone-based self-management platform to support medication adherence and clinical consultation in Parkinson's disease.NPJ Parkinson's disease · 2017
    Article
16. No Difference on Adherence Between Immediate-Release Versus Extended-Release Dopamine Agonists in Uninsured Subjects with Parkinson's Disease.Movement disorders clinical practice
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

2 authors.

Funding

Abstract

PubMed holds no abstract for this paper.

Indexed as